Tofacitinib-induced ramsay- hunt syndrome in a patient with rheumatoid arthritis

Basit Öğe Kaydı
dc.authoridŞenol Kobak / 0000-0001-8270-640Xen_US
dc.authorscopusidŞenol Kobak / 12782228700
dc.authorwosidŞenol Kobak / AAO-2482-2020
dc.contributor.authorKobak, Şenol
dc.date.accessioned2020-09-25T08:56:51Z
dc.date.available2020-09-25T08:56:51Z
dc.date.issued2021en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractBackground: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint and systemic involvement. Tofacitinib is a JAK- inhibitor that is an effective agent in the treatment of active RA. Varicella zoster virus (VZV) reactivation is among the most important advers effects of tofacitinib. Ramsay-Hunt syndrome (RHS) is a rare clinical condition that develop as a result of VZV reactivation and progresses with hearing loss, dizziness and facial nerve paralysis. Objective: To present a case with Ramsay-Hunt syndrome due to varicella zoster reactivation in RA patient using tofacitinib. Case report: A 63-year-old female RA patient under tofacitinib treatment was admitted to the rheumatology outpatient clinic due to widespread skin rashes on her face and ear, and hearing loss. On inspection widespread erythematous, vesicular rashes on the left side of the face, lips, around the eye and in the ear, and mild facial paralysis on the left side were detected. On laboratory investigations acute phase reactants were increased. Serological study for specific antibodies against varicella zoster virus showed higher titers. Dermatology and ear nose throat specialist consultations was performed, varicella zoster lesions on the left inner ear, face and mild facial paresis were considered. According to clinical and laboratory findings the patient was diagnosed with RHS triggered by tofacitinib. Tofacitinib and methotrexate was discontinued, and intravenous acyclovir was started. On the control examination the patient's skin lesions and facial nerve paralysis regressed. Conclusion: Herein we reported the fırst case of tofacitinib-induced RHS in a patient with RA. This is may be the another side effect of biologic treatment. New studies are needed in this subject.en_US
dc.identifier.citationKobak, S. Tofacitinib-induced Ramsay-Hunt Syndrome in a Patient with Rheumatoid Arthritis. Current drug safety.en_US
dc.identifier.doi10.2174/1574886315999200819153827en_US
dc.identifier.pmid32819263en_US
dc.identifier.scopus2-s2.0-85102499879en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.urihttps://doi.org/10.2174/1574886315999200819153827
dc.identifier.urihttps://hdl.handle.net/20.500.12713/1108
dc.identifier.wosWOS:000624639200012en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorKobak, Şenol
dc.language.isoenen_US
dc.relation.ispartofCurr Drug Safen_US
dc.relation.publicationcategoryRaporen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTofacitiniben_US
dc.subjectRamsay-Hunt Syndromeen_US
dc.subjectRheumatoid Arthritisen_US
dc.subjectVaricela Zosteren_US
dc.titleTofacitinib-induced ramsay- hunt syndrome in a patient with rheumatoid arthritisen_US
dc.typeReporten_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

PubMed İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu